Virulence profiles of bacteremic extended-spectrum β-lactamase-producing Escherichia coli: association with epidemiological and clinical features

PLoS One. 2012;7(9):e44238. doi: 10.1371/journal.pone.0044238. Epub 2012 Sep 7.

Abstract

There is scarce data about the importance of phylogroups and virulence factors (VF) in bloodstream infections (BSI) caused by extended-spectrum β-lactamase-producing Escherichia coli (ESBLEC). A prospective multicenter Spanish cohort including 191 cases of BSI due to ESBLEC was studied. Phylogroups and 25 VF genes were investigated by PCR. ESBLEC were classified into clusters according to their virulence profiles. The association of phylogropus, VF, and clusters with epidemiological features were studied using multivariate analysis. Overall, 57.6%, 26.7%, and 15.7% of isolates belonged to A/B1, D and B2 phylogroups, respectively. By multivariate analysis (adjusted OR [95% CI]), virulence cluster C2 was independently associated with urinary tract source (5.05 [0.96-25.48]); cluster C4 with sources other than urinary of biliary tract (2.89 [1.05-7.93]), and cluster C5 with BSI in non-predisposed patients (2.80 [0.99-7.93]). Isolates producing CTX-M-9 group ESBLs and from phylogroup D predominated among cluster C2 and C5, while CTX-M-1 group of ESBL and phylogroup B2 predominantes among C4 isolates. These results suggest that host factors and previous antimicrobial use were more important than phylogroup or specific VF in the occurrence of BSI due to ESBLEC. However, some associations between virulence clusters and some specific epidemiological features were found.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Infective Agents / pharmacology
  • Bacteremia / microbiology*
  • Bacteremia / pathology*
  • Drug Resistance, Bacterial / drug effects
  • Drug Resistance, Bacterial / genetics
  • Escherichia coli / classification
  • Escherichia coli / enzymology*
  • Escherichia coli / genetics
  • Escherichia coli / pathogenicity*
  • Escherichia coli Infections / epidemiology*
  • Escherichia coli Infections / microbiology*
  • Escherichia coli Infections / pathology
  • Female
  • Genes, Bacterial / genetics
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Multigene Family / genetics
  • Multivariate Analysis
  • Phylogeny
  • Spain
  • Virulence / drug effects
  • Virulence / genetics
  • Virulence Factors / genetics
  • beta-Lactamases / biosynthesis*

Substances

  • Anti-Infective Agents
  • Virulence Factors
  • beta-Lactamases

Grants and funding

This study was funded by the Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III - co-financed by European Development Regional Fund “A way to achieve Europe” ERDF, Spanish Network for Research in Infectious Diseases (REIPI RD06/0008), Fondo de Investigación Sanitaria (grants 070190, 10/02021, 10/01955, and 10/00795), and Junta de Andalucía (grants 0048/2008, and CTS-5259). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.